Joint Operating Committee. (a) The Joint Operating Committee ("JOC") shall consist of an equal number of members from each of Eyetech and Pfizer. Each of Eyetech and Pfizer shall confirm to the other its designees. At least one of Pfizer's designees shall be the Vice President in Pfizer's Pharmaceuticals Group with global responsibility for the therapeutic area covering the Products. The JOC shall address all of the significant and strategic issues within the purview of the various subcommittees, and shall be responsible for resolving any issues referred by the subcommittees. The JOC will be presented with updates on the activities and achievements of the subcommittees. All decisions of the JOC will be unanimous votes of the co-chairpersons. (b) If the JOC is unable to resolve any issue within ten (10) Business Days after presentation, either Party may refer the issue to the Senior Executives for resolution pursuant to Section 3.7.
Appears in 3 contracts
Sources: Collaboration Agreement (Eyetech Pharmaceuticals Inc), Collaboration Agreement (Eyetech Pharmaceuticals Inc), Collaboration Agreement (Osi Pharmaceuticals Inc)